DBV Technologies Files Q2 2024 10-Q

TL;DR

DBV Tech Q2 10-Q filed. Financials updated.

AI Summary

DBV Technologies S.A. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key financial data and balance sheet items as of June 30, 2024, are presented, including common stock and other assets and liabilities.

Why It Matters

This filing provides investors with the latest financial snapshot of DBV Technologies, crucial for understanding the company's current financial health and operational standing.

Risk Assessment

Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and operational context within this report could indicate varying levels of risk.

Key Numbers

• 2024-06-30 — Reporting Period End Date (Indicates the financial data presented is current as of this date.)
• 2023-12-31 — Previous Year End Date (Provides a comparative point for financial analysis.)

Key Players & Entities

• DBV Technologies S.A. (company) — Filer of the 10-Q
• 2024-06-30 (date) — End of the reporting period
• 0001193125-24-188853 (other) — Accession Number for the filing

FAQ

Filing Documents

• d873714d10q.htm (10-Q) — 1051KB
• d873714dex31.htm (EX-3.1) — 73KB
• d873714dex311.htm (EX-31.1) — 10KB
• d873714dex312.htm (EX-31.2) — 10KB
• d873714dex321.htm (EX-32.1) — 5KB
• 0001193125-24-188853.txt ( ) — 5074KB
• dbvt-20240630.xsd (EX-101.SCH) — 43KB
• dbvt-20240630_cal.xml (EX-101.CAL) — 42KB
• dbvt-20240630_def.xml (EX-101.DEF) — 197KB
• dbvt-20240630_lab.xml (EX-101.LAB) — 294KB
• dbvt-20240630_pre.xml (EX-101.PRE) — 261KB
• d873714d10q_htm.xml (XML) — 802KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 21 Item 4

Controls and Procedures

Controls and Procedures 21 Part II Other Information 23 Item 1

Legal Proceedings

Legal Proceedings 23 Item 1A

Risk Factors

Risk Factors 23 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds 23 Item 3 Defaults Upon Senior Securities 23 Item 4 Mine Safety Disclosures 23 Item 5 Other Information 23 Item 6 Exhibits 24 Unless the context otherwise requires, we use the terms "DBV", "DBV Technologies," the "Company," "we," "us" and "our" in this Quarterly Report on Form 10-Q, or Quarterly Report, to refer to DBV Technologies S.A. and, where appropriate, its consolidated subsidiaries. "Viaskin ", "EPIT " and our other registered and common law trade names, trademarks and service marks are the property of DBV Technologies S.A. or our subsidiaries. All other trademarks, trade names and service marks appearing in this Quarterly Report are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Quarterly Report may be referred to without the and symbols, but such references should not be construed as any indicator that their respective owners will not assert their rights thereto. Table of Contents SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS This Quarterly Report contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements may be identified by such forward-looking terminology as "may," "should," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or variations of these words or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Any forward-looking statement involves known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements DBV Technologies S.A. Condensed Consolidated Statements of Financial Position (unaudited) (amounts in thousands, except share and per share data) Note June 30, 2024 December 31, 2023 Assets Current assets : Cash and cash equivalents 3 66,213 141,367 Other current assets 4 23,745 17,548 Total current assets 89,958 158,915 Property, plant, and equipment, net 12,874 12,623 Right-of-use assets related to operating leases 5 5,959 5,247 Intangible assets 46 58 Other non-current assets 5,353 6,144 Total non-current assets 24,232 24,071 Total Assets 114,190 182,986 Liabilities and shareholders' equity Current liabilities: Trade payables 6 19,818 23,302 Short-term operating leases 5 380 1,144 Current contingencies 9 1,023 3,959 Other current liabilities 6 6,160 8,934 Total current liabilities 27,381 37,339 Long-term operating leases 5 6,783 4,526 Non-current contingencies 9 931 935 Other non-current liabilities 6 — — Total non-current liabilities 7,714 5,461 Total Liabilities 35,095 42,799 Shareholders' equity : Ordinary shares, 0.10 par value; 96,493,078 and 96,431,770 shares authorized, and issued as at June 30, 2024 and December 31, 2023, respectively 10,978 10,972 Additional paid-in capital 314,513 377,468 Treasury stock 303,744 , and 222,988 ordinary shares as of June 30, 2024 and December 31, 2023, respectively, at cost ( 1,358 ) ( 1,263 ) Accumulated deficit ( 232,890 ) ( 238,862 ) Accumulated other comprehensive income 750 742 Accumulated currency translation effect ( 12,898 ) ( 8,871 ) Total Shareholders' equity 7 79,095 140,187 Total Liabilities and Shareholder's equity 114,190 182,986 The accompanying notes are an integral part of these condensed consolidated financial statements. 2 DBV Technologies S.A. Condensed Consolidated Statements of Operations and Compreh

View Full Filing

View this 10-Q filing on SEC EDGAR